Charles Schwab Investment Management Inc Biomarin Pharmaceutical Inc Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,401,628 shares of BMRN stock, worth $87.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,401,628

Previous 1,345,929 4.14%

Holding current value

$87.5 Million

Previous $111 Million 11.09%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$69.02 - $93.84 $3.84 Million - $5.23 Million	55,699 Added 4.14%	1,401,628 $98.5 Million
Q2 2024 Aug 12, 2024	BUY	$74.43 - $92.22 $343,420 - $425,503	4,614 Added 0.34%	1,345,929 $111 Million
Q1 2024 May 08, 2024	SELL	$83.81 - $99.0 $3.15 Million - $3.72 Million	-37,582 Reduced 2.73%	1,341,315 $117 Million
Q4 2023 Feb 06, 2024	BUY	$76.22 - $98.51 $5.65 Million - $7.3 Million	74,100 Added 5.68%	1,378,897 $133 Million
Q3 2023 Nov 08, 2023	BUY	$85.07 - $94.48 $2.86 Million - $3.17 Million	33,592 Added 2.64%	1,304,797 $115 Million
Q2 2023 Aug 09, 2023	BUY	$86.68 - $100.3 $1.06 Million - $1.22 Million	12,173 Added 0.97%	1,271,205 $110 Million
Q1 2023 May 11, 2023	BUY	$87.74 - $117.27 $1.5 Million - $2 Million	17,052 Added 1.37%	1,259,032 $122 Million
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $2.18 Million - $2.93 Million	26,963 Added 2.22%	1,241,980 $129 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $1.06 Million - $1.25 Million	12,907 Added 1.07%	1,215,017 $103 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $5.3 Million - $6.43 Million	74,080 Added 6.57%	1,202,110 $99.6 Million
Q1 2022 May 13, 2022	BUY	$74.28 - $92.69 $2.01 Million - $2.51 Million	27,091 Added 2.46%	1,128,030 $87 Million
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $3.55 Million - $4.53 Million	49,535 Added 4.71%	1,100,939 $97.3 Million
Q3 2021 Nov 16, 2021	BUY	$74.77 - $85.47 $32.5 Million - $37.2 Million	435,084 Added 70.59%	1,051,404 $81.3 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $2.63 Million - $2.96 Million	34,886 Added 6.0%	616,320 $51.4 Million
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $8.43 Million - $10.2 Million	-112,796 Reduced 16.25%	581,434 $43.9 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $856,289 - $1.06 Million	11,793 Added 1.73%	694,230 $60.9 Million
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $4.31 Million - $7.86 Million	60,022 Added 9.64%	682,437 $51.9 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $2.05 Million - $3.2 Million	25,784 Added 4.32%	622,415 $76.8 Million
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $1.5 Million - $2.04 Million	21,061 Added 3.66%	596,631 $50.4 Million
Q4 2019 Feb 07, 2020	BUY	$64.27 - $86.37 $5.41 Million - $7.27 Million	84,123 Added 17.12%	575,570 $48.7 Million
Q3 2019 Nov 08, 2019	BUY	$67.4 - $85.11 $1.59 Million - $2.01 Million	23,637 Added 5.05%	491,447 $33.1 Million
Q2 2019 Aug 09, 2019	BUY	$80.35 - $93.9 $1.8 Million - $2.1 Million	22,343 Added 5.02%	467,810 $40.1 Million
Q1 2019 May 14, 2019	BUY	$84.2 - $98.62 $2.23 Million - $2.61 Million	26,427 Added 6.31%	445,467 $39.6 Million
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $1.83 Million - $2.42 Million	22,812 Added 5.76%	419,040 $35.7 Million
Q3 2018 Nov 13, 2018	BUY	$93.92 - $105.72 $1.96 Million - $2.21 Million	20,862 Added 5.56%	396,228 $38.4 Million
Q2 2018 Aug 08, 2018	BUY	$76.01 - $99.03 $1.57 Million - $2.05 Million	20,685 Added 5.83%	375,366 $35.4 Million
Q1 2018 May 07, 2018	BUY	$77.67 - $92.63 $1.46 Million - $1.74 Million	18,782 Added 5.59%	354,681 $28.8 Million
Q4 2017 Jan 17, 2018	BUY	$80.76 - $95.13 $1.24 Million - $1.47 Million	15,414 Added 4.81%	335,899 $30 Million
Q3 2017 Nov 13, 2017	BUY	$80.6 - $94.95 $25.8 Million - $30.4 Million	320,485	320,485 $29.8 Million

Others Institutions Holding BMRN

# of Institutions

645

Shares Held

178M

Call Options Held

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.6B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Biomarin Pharmaceutical Inc Transaction History